Skip to content
← Full study record

NCT01083706 · MORE INFO

Limitations, agreements, and source contact

Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant · Source last updated 2017-05-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
bscott@fredhutch.org
organization
Fred Hutchinson Cancer Research Center
phone
206-667-1990
title
Bart Scott
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
bscott@fredhutch.org
organization
Fred Hutchinson Cancer Research Center
phone
206-667-1990
title
Bart Scott

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice